Home › Funds › Pentwater Capital Management LP › TECH
Pentwater Capital Management LP position in TECH
BIO-TECHNE CORP · Health Care
Pentwater Capital Management LP reported holding 350,000 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$25.4M, representing 0.37% of its reported portfolio and ranking #31 among its reported holdings. Pentwater Capital Management LP has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Pentwater Capital Management LP's TECH position evolved
Pentwater Capital Management LP first disclosed a stake in TECH in Q2 2026 at 500,000 shares (US$35.3M). Across 2 filings, Pentwater Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 350,000 shares valued at US$25.4M — a reduction of -150,000 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 500.00K | $35.33M | New |
| Q3 2026 | 350.00K | $25.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TECH and 13F data
TECH (BIO-TECHNE CORP) is a Health Care company. 26 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$560.3M), Balyasny Asset Management (US$246.7M), Ruane Cunniff & Goldfarb (Sequoia) (US$242.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TECH
- HBK INVESTMENTS L P 7.73M sh · $560.35M · Q3 2026
- Balyasny Asset Management 3.40M sh · $246.67M · Q3 2026
- Ruane Cunniff & Goldfarb (Sequoia) 3.34M sh · $242.26M · Q3 2026
- WHITEBOX ADVISORS LLC 2.62M sh · $190.15M · Q3 2026
- Qube Research & Technologies Ltd 2.38M sh · $172.44M · Q3 2026
- RGM Capital, LLC 2.15M sh · $126.56M · Q4 2025
More on Pentwater Capital Management LP
FAQ
How long has Pentwater Capital Management LP held TECH?
Pentwater Capital Management LP has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Pentwater Capital Management LP's current position in TECH?
As of Q3 2026, Pentwater Capital Management LP holds 350.00K shares of TECH (BIO-TECHNE CORP), valued at $25.36M, representing 0.37% of its reported portfolio and ranking #31.
Has Pentwater Capital Management LP been buying or selling TECH?
In the latest 13F filing (Q3 2026), Pentwater Capital Management LP reduced its position in TECH.
Which other funds hold TECH?
Other major institutional holders of TECH include HBK INVESTMENTS L P, Balyasny Asset Management, Ruane Cunniff & Goldfarb (Sequoia), among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.